Cargando…
Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer
SIMPLE SUMMARY: Adrenocortical cancer (ACC) is a rare malignancy with a poor prognosis and few treatment options. Surgery is the only curative option, but many patients present after the disease has become metastatic or recurs after surgery. There have been few advances in treatment since mitotane’s...
Autores principales: | Michael, Nicholas, Nilubol, Naris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654521/ https://www.ncbi.nlm.nih.gov/pubmed/36358665 http://dx.doi.org/10.3390/cancers14215245 |
Ejemplares similares
-
Current Status and Future Targeted Therapy in Adrenocortical Cancer
por: Alyateem, George, et al.
Publicado: (2021) -
Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
por: Nilubol, Naris, et al.
Publicado: (2012) -
SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019) -
Preclinical Models of Adrenocortical Cancer
por: Sedlack, Andrew J. H., et al.
Publicado: (2023) -
Adrenocortical carcinoma and pulmonary embolism from tumoral extension
por: Shekhar, Skand, et al.
Publicado: (2019)